PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 31 filers reported holding PROTARA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $106,880 | -30.1% | 64,000 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $152,960 | -22.9% | 64,000 | 0.0% | 0.00% | -20.0% |
| Q1 2023 | $198,400 | +15.7% | 64,000 | 0.0% | 0.01% | +25.0% |
| Q4 2022 | $171,520 | -9.2% | 64,000 | 0.0% | 0.00% | -20.0% |
| Q3 2022 | $189,000 | +0.5% | 64,000 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $188,000 | -42.5% | 64,000 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $327,000 | -9.4% | 64,000 | +19.6% | 0.01% | -14.3% |
| Q4 2021 | $361,000 | -53.7% | 53,500 | -52.4% | 0.01% | -53.3% |
| Q3 2021 | $779,000 | – | 112,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,674,031 | $13,664,000 | 4.24% |
| Ikarian Capital, LLC | 296,426 | $1,515,000 | 0.20% |
| DLD Asset Management, LP | 229,531 | $1,173,000 | 0.07% |
| Orbimed Advisors | 830,641 | $4,245,000 | 0.07% |
| Boxer Capital, LLC | 209,227 | $1,069,000 | 0.06% |
| Perceptive Advisors | 383,526 | $1,960,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 64,000 | $327,000 | 0.01% |
| Baker Brothers Advisors | 199,671 | $1,020,000 | 0.01% |
| Trexquant Investment LP | 16,313 | $83,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 27,591 | $141,000 | 0.00% |